These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15454355)

  • 21. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002.
    Sullivan PW; Morrato EH; Ghushchyan V; Wyatt HR; Hill JO
    Diabetes Care; 2005 Jul; 28(7):1599-603. PubMed ID: 15983307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of medical expenditures and quality of life in US adults with diabetes: the medical expenditure panel survey, 2002-2011.
    Campbell JA; Bishu KG; Walker RJ; Egede LE
    Health Qual Life Outcomes; 2017 Apr; 15(1):70. PubMed ID: 28407776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cost of cancer care in Portugal].
    Araújo A; Barata F; Barroso S; Cortes P; Damasceno M; Parreira A; Espírito Santo J; Teixeira E; Pereira R
    Acta Med Port; 2009; 22(5):525-36. PubMed ID: 19944035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic costs associated with physical inactivity and obesity in Canada: an update.
    Katzmarzyk PT; Janssen I
    Can J Appl Physiol; 2004 Feb; 29(1):90-115. PubMed ID: 15001807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persons with chronic conditions. Their prevalence and costs.
    Hoffman C; Rice D; Sung HY
    JAMA; 1996 Nov; 276(18):1473-9. PubMed ID: 8903258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Feldman DI; Valero-Elizondo J; Salami JA; Rana JS; Ogunmoroti O; Osondu CU; Spatz ES; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Atherosclerosis; 2017 Mar; 258():79-83. PubMed ID: 28214425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimates of state-level health-care expenditures associated with disability.
    Anderson WL; Armour BS; Finkelstein EA; Wiener JM
    Public Health Rep; 2010; 125(1):44-51. PubMed ID: 20402195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of morbid obesity on medical expenditures in adults.
    Arterburn DE; Maciejewski ML; Tsevat J
    Int J Obes (Lond); 2005 Mar; 29(3):334-9. PubMed ID: 15685247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States.
    Qureshi AI; Suri MF; Kirmani JF; Divani AA
    Stroke; 2004 Oct; 35(10):2346-50. PubMed ID: 15345797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003.
    Banthin JS; Bernard DM
    JAMA; 2006 Dec; 296(22):2712-9. PubMed ID: 17164457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 - United States, 2011-2016.
    Wall HK; Ritchey MD; Gillespie C; Omura JD; Jamal A; George MG
    MMWR Morb Mortal Wkly Rep; 2018 Sep; 67(35):983-991. PubMed ID: 30188885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct medical costs of hospitalizations for cardiovascular diseases in Shanghai, China: trends and projections.
    Wang S; Petzold M; Cao J; Zhang Y; Wang W
    Medicine (Baltimore); 2015 May; 94(20):e837. PubMed ID: 25997060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.
    Yelin E; Herrndorf A; Trupin L; Sonneborn D
    Arthritis Rheum; 2001 May; 44(5):1160-9. PubMed ID: 11352250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Expenditures Associated With Hypertension in the U.S., 2000-2013.
    Zhang D; Wang G; Zhang P; Fang J; Ayala C
    Am J Prev Med; 2017 Dec; 53(6S2):S164-S171. PubMed ID: 29153117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental expenditure of treating hypertension in the United States.
    Balu S; Thomas J
    Am J Hypertens; 2006 Aug; 19(8):810-6; discussion 817. PubMed ID: 16876679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.